Showing results (221-230 of 231) with videos related to
Sort By:
Pageof 24
Trials|March 26, 2016
An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxisDavid I Dolling, Monica Desai, Alan McOwan, et al.The Lancet. HIV|October 2, 2015
Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: results from the cross-sectional ASTRA studyMarina Daskalopoulou, Alison Rodger, Andrew N Phillips, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 7, 2016
Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH StudySarah Lilian Pett, Janaki Amin, Andrejz Horban, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|September 10, 2014
Predictors of outcome at 1 year in adolescents with DSM-5 restrictive eating disorders: report of the national eating disorders quality improvement collaborativeSara F Forman, Nicole McKenzie, Rebecca Hehn, et al.Lancet (London, England)|September 14, 2015
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trialSheena McCormack, David T Dunn, Monica Desai, et al.JMIR Research Protocols|April 20, 2016
A Cross-Sectional Study on Attitudes to and Understanding of Risk of Acquisition of HIV: Design, Methods and Participant CharacteristicsJaney Sewell, Andrew Speakman, Andrew N Phillips, et al.The Lancet. Infectious Diseases|February 15, 2014
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trialRichard B Pollard, Jürgen K Rockstroh, Giuseppe Pantaleo, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Predictors of renal outcome in HIV-associated nephropathyFrank A Post, Lucy J Campbell, Lisa Hamzah, et al.HIV Medicine|July 27, 2012
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012Ian Williams, Duncan Churchill, Jane Anderson, et al.The Journal of Infectious Diseases|October 3, 2017
Evaluating the Impact of Functional Genetic Variation on HIV-1 ControlPaul J McLaren, Sara L Pulit, Deepti Gurdasani, et al.Pageof 24